I agree that this site is using cookies. You can find further informations here.
X
Came, Neil
23  results:
Search for persons X
?
1

Immunophenotypic characterisation of acute myeloid leukaemi..:

Harrop, Sean ; Nguyen, Phillip C. ; Robinson, Samuel...
British Journal of Haematology.  204 (2024)  6 - p. 2492-2495 , 2024
Link: https://doi.org/10.1111/..
 
?
2

T-cell clones of uncertain significance in the era of incre..:

Potezny, Tessa ; Baldwin, Kylie ; Nguyen, Vuong...
Pathology.  56 (2024)  - p. S24 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Issue highlights—April 2024:

Came, Neil
Cytometry Part B: Clinical Cytometry.  106 (2024)  2 - p. 89-91 , 2024
Link: https://doi.org/10.1002/..
 
?
4

Computational flow cytometry provides accurate assessment o..:

Nguyen, Phillip C. ; Nguyen, Vuong ; Baldwin, Kylie...
British Journal of Haematology.  202 (2023)  4 - p. 760-770 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Evaluation of T‐cell clonality by anti‐TRBC1 antibody‐based..:

Nguyen, Phillip C. ; Nguyen, Tamia ; Wilson, Clarissa...
British Journal of Haematology.  204 (2023)  3 - p. 910-920 , 2023
Link: https://doi.org/10.1111/..
 
?
6

Evaluation of multiple myeloma measurable residual disease ..:

Soh, Kah Teong ; Came, Neil ; Otteson, Gregory E....
Cytometry Part B: Clinical Cytometry.  102 (2022)  2 - p. 88-106 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Unsupervised computational detection of measurable residual..:

Nguyen, Phillip C. ; Nguyen, Vuong ; Came, Neil.
Pathology.  54 (2022)  - p. S30-S31 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Minimal residual disease in multiple myeloma: defining the ..:

Maclachlan, Kylee H. ; Came, Neil ; Diamond, Benjamin...
Pathology.  53 (2021)  3 - p. 385-399 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Validation of a modified pre‐lysis sample preparation techn..:

Bayly, Emma ; Nguyen, Vuong ; Binek, Adrian...
Cytometry Part B: Clinical Cytometry.  98 (2020)  5 - p. 385-398 , 2020
Link: https://doi.org/10.1002/..
 
?
10

A synonymousGATA2variant underlying familial myeloid malign..:

Fox, Lucy C. ; Tan, Michelle ; Brown, Anna L....
British Journal of Haematology.  190 (2020)  5 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
11

Undetectable peripheral blood MRD should be the goal of ven..:

Lew, Thomas E. ; Anderson, Mary Ann ; Lin, Victor S....
Blood Advances.  4 (2020)  1 - p. 165-173 , 2020
Link: https://doi.org/10.1182/..
 
?
12

Should we be routinely testing for circulating clonal plasm..:

Came, Neil
Cytometry Part B: Clinical Cytometry.  94 (2018)  5 - p. 715-715 , 2018
Link: https://doi.org/10.1002/..
 
?
13

Aggressive and extramedullary plasma cell myeloma evade bon..:

Came, Neil ; Nguyen, Vuong ; Westerman, David.
British Journal of Haematology.  173 (2015)  6 - p. 947-949 , 2015
Link: https://doi.org/10.1111/..
 
?
14

Consensus guidelines on plasma cell myeloma minimal residua..:

Arroz, Maria ; Came, Neil ; Lin, Pei...
Cytometry Part B: Clinical Cytometry.  90 (2015)  1 - p. 31-39 , 2015
Link: https://doi.org/10.1002/..
 
?
15

The denominator variable in the quantitation of MRD in acut..:

Came, Neil ; Westerman, David ; Juneja, Surender
American Journal of Hematology.  90 (2015)  11 - p. , 2015
Link: https://doi.org/10.1002/..
 
1-15